Cargando…
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
Secretory leukocyte protease inhibitor (SLPI), a pleiotropic protein expressed by healthy intestinal epithelial cells, functions as an inhibitor of NF-κB and neutrophil proteases and exerts antimicrobial activity. We previously showed SLPI suppresses intestinal epithelial chemokine production in res...
Autores principales: | Nugteren, Sandrine, Goos, Jeroen A.C.M., Delis-van Diemen, Pien M., Simons-Oosterhuis, Ytje, Lindenbergh-Kortleve, Dicky J., van Haaften, Daniëlle H., Sanders, Joyce, Meijer, Gerrit A., Fijneman, Remond J.A., Samsom, Janneke N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556627/ https://www.ncbi.nlm.nih.gov/pubmed/33101778 http://dx.doi.org/10.1080/2162402X.2020.1832761 |
Ejemplares similares
-
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022) -
Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
por: Nugteren, Sandrine, et al.
Publicado: (2022) -
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017) -
Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008) -
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
por: Goos, Jeroen A.C.M., et al.
Publicado: (2015)